Overview

Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
We hypothesize that those patients with purely seasonal allergic rhinitis will decongest better than those subjects with another cause contributing to their symptoms. These latter patients will not improve as well on an intranasal steroid as those who decongest well, potentially explaining the 60% response rate in prior studies.
Phase:
N/A
Details
Lead Sponsor:
University of Chicago
Collaborator:
Schering-Plough
Treatments:
Ephedrine
Mometasone Furoate
Nasal Decongestants
Pseudoephedrine